Lv41
636 积分 2022-07-22 加入
Next-generation endocrine therapy in HR+/HER2 − breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation–guided switching
51分钟前
已完结
新型口服SERD在ER(＋)/Her-2(－)乳腺癌中的临床研究及应用前景
2小时前
已完结
Ivonescimab: First Approval
16天前
已完结
A translational framework for extrahepatic oligonucleotide delivery
1个月前
已完结
Beyond the breakthrough for RAS-driven cancers
1个月前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
1个月前
已完结
The story of amylin: from physiology to therapy
1个月前
已完结
Advancing Diabetes Management and Glycemic Control While Exploring CagriSema’s Impact on Obesity Management
1个月前
已完结
Medical Treatments for Obesity: What Does the Future Have in Store?
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
皖公网安备34019202002308
